A comprehensive view of Weight Issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly lists Phase 2 interventional clinical trial to investigate weight management with LY3841136 compared with placebo in adult participants with obesity or overweight
Published: January 31, 2024 by Contify Life Science News
Executive Perspective: Nestle working on products to accompany weight-loss drugs like Ozempic, Wegovy and Mounjaro, as the food industry evolves in response to the soaring popularity of the appetite-killing drugs, says CEO Mark Schneider
Published: October 19, 2023 by Forbes
Commentary: Action on Sugar’s recent call for a ban on child-orientated packaging on cereal is a call for creeping regulatory overreach to accelerate, ignores the science around weight loss, represents a slippery slope toward complete brand erosion
Published: September 11, 2023 by Grocer (UK)
Goldman Sachs sees obesity dragging world GDP down by US$4T in 2035, but weight-loss drugs could change that; Novo Nordisk study finds Wegovy reduced chance of heart attacks, strokes and cardiovascular deaths by 20%, could help with sleep apnea, addiction
Published: September 08, 2023 by Business Insider
Commentary: Despite popularity of weight loss drugs, US retailers see minimal profit due to low gross margins on branded medications; while increased foot traffic could lead to multiple purchases for Walmart, impact varies for Rite Aid, CVS and Walgreens
Published: August 22, 2023 by MarketLine

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count